Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
Launched by BAYLOR COLLEGE OF MEDICINE · Aug 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether acupuncture can help reduce nausea and vomiting after a specific type of surgery called laparoscopic cholecystectomy, which is done to remove the gallbladder. The researchers want to see if adding acupuncture to standard medications (ondansetron and dexamethasone) will be more effective in preventing these uncomfortable symptoms than just using the medications alone.
To participate in this trial, you need to be between 18 and 64 years old and scheduled for a laparoscopic cholecystectomy at Harris Health System Ben Taub Hospital. You should be in good health, with no major issues like kidney problems or allergies to anesthesia. If you join the study, you can expect to receive acupuncture during your surgery along with the usual medications to see if this combination helps you feel better afterward. It's important to know that if you have certain conditions or if your doctor feels it's not right for you, you may not be able to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient ages 18-64
- • 2. American Society of Anesthesiology Physical Status I, II or III
- • 3. Patients scheduled to undergo laparoscopic cholecystectomy at Harris Health System Ben Taub Hospital
- Exclusion Criteria:
- • 1. Scheduled open cholecystectomy - excluded due to increased levels of pain in open procedures
- • 2. Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential altered metabolism of anesthetic and perioperative medications
- • 3. Allergy to any of the standard anesthetic agents
- • 4. Patient inability to properly communicate with investigators (language barrier, dementia, delirium, psychiatric disorder)
- • 5. Patient or surgeon refusal
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported